Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: A Children's Cancer Group study

Journal of Clinical Oncology

Volumn 18, Issue 1, 2000, Pages 18-26

  Perez, Carlos A ^a   Matthay, Katherine K ^a   Atkinson, James B ^a   Seeger, Robert C ^a   Shimada, Hiroyuki ^a   Haase, Gerald M ^a   Stram, Daniel O ^a   Gerbing, Robert B ^a   Lukens, John N ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; SPINAL CORD COMPRESSION; TREATMENT OUTCOME;

EID: 0033987789     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.2000.18.1.18     Document Type: Article

References (37)

1. Berthold F, Brandeis WE, Lampert F: Neuroblastoma: Diagnostic advances and therapeutic results in 370 patients. Monogr Paediatr 18:206-223, 1996
2. Kinnier-Wilson LM, Draper GJ: Neuroblastoma, its natural history and prognosis: A study of 487 cases. BMJ 3:301-307, 1974
3. Evans AR, Brand W, de Lorimier A, et al: Results in children with local and regional neuroblastoma managed with and without vincristine, cyclophosphamide, and imidazolecarboxamide: A report from the Children's Cancer Study Group. Am J Clin Oncol 7:3-7, 1984
4. Hayes FA, Green A, Hustu HO, et al: Surgicopathologic staging of neuroblastoma: Prognostic significance of regional lymph node metastases. J Pediatrics 102:59-62, 1983
5. Kushner BH, Cheung NK, LaQuaglia MP, et al: Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy. J Clin Oncol 14:373-381, 1996
6. Matthay KK, Sather HN, Seeger RC, et al: Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol 7:236-244, 1989
7. Nitschke R, Smith EI, Shochat S, et al: Localized neuroblastoma treated by surgery: A Pediatric Oncology Group study. J Clin Oncol 6:1271-1279, 1988
8. Brodeur GM, Seeger RC, Schwab M, et al: Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121-1124, 1984
9. Brodeur GM, Seeger RC, Sather H, et al: Clinical implications of oncogene activation in human neuroblastomas. Cancer 58:541-545, 1986
10. Seeger RC, Brodeur GM, Sather H, et al: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111-1116, 1985
11. Hann HW, Evans AE, Siegel SE, et al: Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: The Childrens Cancer Study Group experience. Cancer Res 45:2843-2848, 1985
12. Shimada H, Chatten J, Newton WA Jr, et al: Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73:405-416, 1984
13. Zeltzer PM, Marangos PJ, Evans AE, et al: Serum neuron-specific enolase in children with neuroblastoma: Relationship to stage and disease course. Cancer 57:1230-1234, 1986
14. Evans AE, D'Angio GJ, Randolph J: A proposed staging for children with neuroblastoma: Children's Cancer Study Group A. Cancer 27:374-378, 1971
15. Moss TJ, Reynolds CP, Sather HN, et al: Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N Engl J Med 324:219-226, 1991
16. Fabbretti G, Valenti C, Loda M, et al: N-myc gene amplification/expression in localized stroma-rich neuroblastoma (ganglioneuroblastoma). Hum Pathol 24:294-297, 1993
17. Conn SL, Look AT, Joshi VV, et al: Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: A Pediatric Oncology Group study. Cancer Res 55:721-726, 1995
18. Seeger RC, Wada R, Brodeur GM, et al: Expression of N-myc by neuroblastomas with one or multiple copies of the oncogene. Prog Clin Biol Res 271:41-49, 1988
19. Brodeur GM, Pritchard J, Berthold F, et al: Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment [see comments]. J Clin Oncol 11:1466-1477, 1993
20. Matthay KK, Perez C, Seeger RC, et al: Successful treatment of stage III neuroblastoma based on prospective biologic staging: A Children's Cancer Group study. J Clin Oncol 16:1256-1264, 1998
21. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
22. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, John Wiley and Sons, Inc, 1980
23. Evans AE, Silber JH, Shpilsky A, et al: Successful management of low-stage neuroblastoma without adjuvant therapies: A comparison of two decades, 1972 through 1981 and 1982 through 1992, in a single institution. J Clin Oncol 14:2504-2510, 1996
24. De Bernardi B, Conte M, Mancini A, et al: Localized resectable neuroblastoma: Results of the second study of the Italian Cooperative Group for Neuroblastoma. J Clin Oncol 13:884-893, 1995
25. Rubie H, Hartmann O, Michon J, et al: N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: Results of the French NBL 90 study - Neuroblastoma Study Group of the Societe Francaise d'Oncologie Paediatrique. J Clin Oncol 15:1171-1182, 1997
26. Nitschke R, Smith EI, Altshuler G, et al: Postoperative treatment of nonmetastatic visible residual neuroblastoma: A Pediatric Oncology Group study. J Clin Oncol 9:1181-1188, 1991
27. Ninane J, Wese FX: Treatment of localized neuroblastoma. Am J Pediatr Hematol Oncol 8:248-252, 1986
28. Castleberry RP, Kun LE, Shuster JJ, et al: Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma [see comments]. J Clin Oncol 9:789-795, 1991
29. Breslow N, McCann B: Statistical estimation of prognosis for children with neuroblastoma. Cancer Res 31:2098-2103, 1971
30. Stram DO, Matthay KK, O'Leary M, et al: Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: A report of two concurrent Children's Cancer Group studies [see comments]. J Clin Oncol 14:2417-2426, 1996
31. Garaventa A, De Bernardi B, Pianca C, et al: Localized but unresectable neuroblastoma: Treatment and outcome of 145 cases. J Clin Oncol 11:1770-1779, 1993
32. Bowman LC, Castleberry RP, Cantor A, et al: Genetic staging of unresectable or metastatic neuroblastoma in infants: A Pediatric Oncology Group study. J Natl Cancer Inst 89:373-380, 1997
33. Massad M, Haddad F, Slim M, et al: Spinal cord compression in neuroblastoma. Surg Neurol 23:567-572, 1985
34. Plantaz D, Hartmann O, Kalifa C, et al: Localized dumbbell neuroblastoma: A study of 25 cases treated between 1982 and 1987 using the same protocol. Med Pediatr Oncol 21:249-253, 1993
35. Berthold F, Kassenbohmer R, Zieschang J: Multivariate evaluation of prognostic factors in localized neuroblastoma. Am J Pediatr Hematol Oncol 16:107-115, 1994
36. Tonini GP, Boni L, Pession A, et al: MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: The Italian experience with 295 children. J Clin Oncol 15:85-93, 1997
37. Maris JM, Matthay KK: Molecular biology of neuroblastoma. J Clin Oncol 17:2264-2279, 1999